ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.

Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by ...

SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today ...

A Black woman sleeps peacefully surrounded by pills, charts, and various sleep devices. Sleep, the thing we all do each night ...

RMD's growth strategy, rising device demand and solid finances support momentum, but macro pressures and stiff competition could test its outlook.

RPMO₂ features a fully embedded oximeter over maxillary dentition, using buccal vestibule mucosa behind the upper lip.

Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS) , a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and ...

Does mouth taping help with snoring? Learn what the research says, potential risks, and safer, proven treatments that can ...

You can get the Apple Watch Series 11 on Amazon now for just $299, reduced from its usual price of $399, which is $100 or 25% ...

Sleep apnea patients get new alternatives to CPAP machines in 2026, including battery-free implants and oral medications with 47% symptom reduction.

An estimated 1 billion people between the ages of 30 and 69 across the globe suffer from sleep apnea, particularly obstructive sleep apnea, according to a 2019 study. To treat sleep apnea, healthcare ...

Adding as little as 1,700 to 5,500 steps per day can offset the risk of a list of chronic diseases—including obesity, ...